You need to create a user account to read this article.
With a subscription you unlock more content on BioStock.
Lipidor files for bankruptcy after failed study
Solna-based Lipidor announces that its Phase III study with the drug candidate AKP02G2 for mild to moderate plaque psoriasis did not achieve its primary treatment objective. As a result, the company is now filing for bankruptcy at the Stockholm...